Trials / Completed
CompletedNCT00072865
Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer
A Phase II Study of Alimta and Carboplatin in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a nonrandomized study of pemetrexed plus carboplatin, with the primary objective of determining the efficacy of the combination in tumor reduction, in patients with locally advanced or metastatic breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pemetrexed | |
| DRUG | Carboplatin |
Timeline
- Start date
- 2003-06-01
- Completion
- 2005-09-01
- First posted
- 2003-11-13
- Last updated
- 2007-01-26
Locations
2 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT00072865. Inclusion in this directory is not an endorsement.